AnalystsPaul MatteisPaul Matteis's Stock Forecasts
AnalystsPaul Matteis
Analyst Ranking
Bottom 4%
#4836 out of 5020 analysts
Average Return
-8.23%
Win Rate
38%28 out of 74
Risk vs Reward
Poor
Good
Paul Matteis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | +81.42% | $52.97 | $96.10 | 2025-03-04 - 2025-09-17 | Strong Buy |
Alnylam Pharmaceuticals IncALNY | +67.29% | $270.02 | $451.73 | 2025-03-30 - 2025-09-17 | Strong Buy |
Gw Pharmaceuticals PLCGWPH | +64.79% | $98.51 | $162.33 | 2017-10-01 - 2018-10-02 | Buy |
Neurocrine Biosciences IncNBIX | +59.15% | $72.78 | $115.83 | 2017-11-01 - 2018-11-02 | Buy |
Rhythm Pharmaceuticals IncRYTM | +55.30% | $61.88 | $96.10 | 2025-05-28 - 2025-09-17 | Strong Buy |
Paul Matteis Analyst Color
Get additional color on Paul Matteis's coverage of popular stocks
Paul Matteis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 14 | Hold | $455.00 | +17.53% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $174.00 | +21.91% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 4 | Strong Buy | $36.00 | +173.76% | Maintains | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $94.00 | -2.19% | Maintains | 4 months ago |
Vigil Neuroscience IncVIGL | 2 | Hold | $8.00 | -0.62% | Downgrades | 4 months ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $345.00 | -23.63% | Maintains | 6 months ago |
Neumora Therapeutics IncNMRA | 2 | Hold | $2.00 | +37.93% | Downgrades | 6 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $32.00 | +44.01% | Initiates Coverage On | 6 months ago |
Gh Research PLCGHRS | 2 | Strong Buy | $32.00 | +156.00% | Maintains | 7 months ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $11.00 | +118.25% | Initiates Coverage On | 7 months ago |
Uniqure NvQURE | 1 | Strong Buy | $32.00 | +125.99% | Maintains | 9 months ago |
Sage Therapeutics IncSAGE | 5 | Hold | $6.00 | -30.88% | Maintains | 9 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $37.00 | +183.31% | Upgrades | 9 months ago |
Alector IncALEC | 5 | Hold | $4.00 | +35.59% | Downgrades | 9 months ago |
Alto Neuroscience IncANRO | 3 | Strong Buy | $10.00 | +161.78% | Maintains | 10 months ago |
Neurogene IncNGNE | 2 | Strong Buy | $60.00 | +238.79% | Maintains | 10 months ago |
Alkermes PLCALKS | 5 | Strong Buy | $36.00 | +29.17% | Upgrades | 10 months ago |
Biomarin Pharmaceutical IncBMRN | 8 | Strong Buy | $87.00 | N/A | Maintains | a year ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Ionis Pharmaceuticals IncIONS | 4 | Hold | $53.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 5 | Hold | $21.00 | N/A | Maintains | a year ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Biogen IncBIIB | 6 | Strong Buy | $287.00 | N/A | Maintains | 2 years ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Vistagen Therapeutics IncVTGN | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Pepgen IncPEPG | 2 | Strong Buy | $24.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $295.00 | N/A | Maintains | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Strong Buy | $54.00 | N/A | Maintains | 3 years ago |
Athira Pharma IncATHA | 2 | Hold | $50.00 | N/A | Downgrades | 3 years ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Climb Bio IncCLYM | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 4 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 4 | Hold | $140.00 | N/A | Downgrades | 5 years ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 3 | Buy | $60.00 | N/A | Initiates Coverage On | 7 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $2,280.00 | N/A | Maintains | 7 years ago |
Akcea Therapeutics IncAKCA | 2 | Hold | $31.00 | N/A | Maintains | 7 years ago |
Obseva SaOBSVF | 1 | Buy | $18.00 | N/A | Maintains | 8 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $64.00 | N/A | Maintains | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $340.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.